Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.4900 (-1.79%) ($5.3100 - $5.6900) on Thu. Aug. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.52% (three month average) | RSI | 51 | Latest Price | $5.4900(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.3% a day on average for past five trading days. | Weekly Trend | ANPC advances 3.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) LIT(9%) IGOV(8%) PCY(8%) UUP(8%) | Factors Impacting ANPC price | ANPC will decline at least -3.26% in a week (0% probabilities). SHY(-20%) IBB(-11%) XBI(-9%) EDOC(-8%) TBT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.26% (StdDev 6.52%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $5.66 | 5 Day Moving Average | $5.88(-6.63%) | 10 Day Moving Average | $5.88(-6.63%) | 20 Day Moving Average | $5.66(-3%) | To recent high | -33.8% | To recent low | 7.9% | Market Cap | $47m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |